00:51:57

Yale Cancer Center Grand Rounds | March 5, 2019

NCI #10020 - Olaparib Alone or in Combination with Atezolizumab in the Treatment of Patients with HER2- BRCAmt Breast Cancer: From Bench to Bedside and Back - Patricia LoRusso, DO, PhD